Semiconductors
Compare Stocks
2 / 10Stock Comparison
ICHR vs CAMT
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
ICHR vs CAMT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Semiconductors | Semiconductors |
| Market Cap | $2.35B | $7.18B |
| Revenue (TTM) | $959M | $472M |
| Net Income (TTM) | $-51M | $134M |
| Gross Margin | 11.3% | 50.3% |
| Operating Margin | -3.8% | 26.6% |
| Forward P/E | 59.2x | 56.7x |
| Total Debt | $186M | $207M |
| Cash & Equiv. | $98M | $126M |
ICHR vs CAMT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ichor Holdings, Ltd. (ICHR) | 100 | 297.9 | +197.9% |
| Camtek Ltd. (CAMT) | 100 | 1529.9 | +1429.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ICHR vs CAMT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ICHR is the clearest fit if your priority is momentum.
- +225.2% vs CAMT's +194.5%
CAMT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.99, yield 0.6%
- Rev growth 36.1%, EPS growth 50.3%, 3Y rev CAGR 16.8%
- 102.6% 10Y total return vs ICHR's 5.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.1% revenue growth vs ICHR's 11.6% | |
| Value | Lower P/E (56.7x vs 59.2x) | |
| Quality / Margins | 28.4% margin vs ICHR's -5.3% | |
| Stability / Safety | Beta 1.99 vs ICHR's 3.93 | |
| Dividends | 0.6% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +225.2% vs CAMT's +194.5% | |
| Efficiency (ROA) | 13.7% ROA vs ICHR's -5.2%, ROIC 13.7% vs -3.9% |
ICHR vs CAMT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ICHR vs CAMT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CAMT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICHR is the larger business by revenue, generating $959M annually — 2.0x CAMT's $472M. CAMT is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to ICHR's -5.3%. On growth, CAMT holds the edge at +20.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $959M | $472M |
| EBITDAEarnings before interest/tax | -$11M | $161M |
| Net IncomeAfter-tax profit | -$51M | $134M |
| Free Cash FlowCash after capex | -$17M | $0 |
| Gross MarginGross profit ÷ Revenue | +11.3% | +50.3% |
| Operating MarginEBIT ÷ Revenue | -3.8% | +26.6% |
| Net MarginNet income ÷ Revenue | -5.3% | +28.4% |
| FCF MarginFCF ÷ Revenue | -1.7% | +26.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.7% | +20.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +46.2% | +21.1% |
Valuation Metrics
ICHR leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.4B | $7.2B |
| Enterprise ValueMkt cap + debt − cash | $2.4B | $7.3B |
| Trailing P/EPrice ÷ TTM EPS | -44.01x | 81.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 59.22x | 56.68x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.33x |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 2.48x | — |
| Price / BookPrice ÷ Book value/share | 3.49x | 17.73x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
CAMT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CAMT delivers a 21.4% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-8 for ICHR. ICHR carries lower financial leverage with a 0.28x debt-to-equity ratio, signaling a more conservative balance sheet compared to CAMT's 0.38x. On the Piotroski fundamental quality scale (0–9), CAMT scores 7/9 vs ICHR's 3/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -7.5% | +21.4% |
| ROA (TTM)Return on assets | -5.2% | +13.7% |
| ROICReturn on invested capital | -3.9% | +13.7% |
| ROCEReturn on capital employed | -4.7% | +14.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 |
| Debt / EquityFinancial leverage | 0.28x | 0.38x |
| Net DebtTotal debt minus cash | $87M | $81M |
| Cash & Equiv.Liquid assets | $98M | $126M |
| Total DebtShort + long-term debt | $186M | $207M |
| Interest CoverageEBIT ÷ Interest expense | -5.97x | 4356.62x |
Total Returns (Dividends Reinvested)
CAMT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAMT five years ago would be worth $63,025 today (with dividends reinvested), compared to $12,419 for ICHR. Over the past 12 months, ICHR leads with a +225.2% total return vs CAMT's +194.5%. The 3-year compound annual growth rate (CAGR) favors CAMT at 94.7% vs ICHR's 33.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +232.0% | +70.7% |
| 1-Year ReturnPast 12 months | +225.2% | +194.5% |
| 3-Year ReturnCumulative with dividends | +137.9% | +638.6% |
| 5-Year ReturnCumulative with dividends | +24.2% | +530.3% |
| 10-Year ReturnCumulative with dividends | +593.7% | +10263.5% |
| CAGR (3Y)Annualised 3-year return | +33.5% | +94.7% |
Risk & Volatility
CAMT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CAMT is the less volatile stock with a 1.99 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.93x | 1.99x |
| 52-Week HighHighest price in past year | $72.87 | $210.20 |
| 52-Week LowLowest price in past year | $13.12 | $62.88 |
| % of 52W HighCurrent price vs 52-week peak | +93.0% | +93.8% |
| RSI (14)Momentum oscillator 0–100 | 65.5 | 52.5 |
| Avg Volume (50D)Average daily shares traded | 793K | 420K |
Analyst Outlook
CAMT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates ICHR as "Buy" and CAMT as "Buy". Consensus price targets imply -16.0% upside for CAMT (target: $166) vs -26.5% for ICHR (target: $50). CAMT is the only dividend payer here at 0.62% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $49.80 | $165.60 |
| # AnalystsCovering analysts | 14 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | — | $1.22 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | — |
CAMT leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ICHR leads in 1 (Valuation Metrics).
ICHR vs CAMT: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ICHR or CAMT a better buy right now?
For growth investors, Camtek Ltd.
(CAMT) is the stronger pick with 36. 1% revenue growth year-over-year, versus 11. 6% for Ichor Holdings, Ltd. (ICHR). Camtek Ltd. (CAMT) offers the better valuation at 81. 5x trailing P/E (56. 7x forward), making it the more compelling value choice. Analysts rate Ichor Holdings, Ltd. (ICHR) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ICHR or CAMT?
On forward P/E, Camtek Ltd.
is actually cheaper at 56. 7x.
03Which is the better long-term investment — ICHR or CAMT?
Over the past 5 years, Camtek Ltd.
(CAMT) delivered a total return of +530. 3%, compared to +24. 2% for Ichor Holdings, Ltd. (ICHR). Over 10 years, the gap is even starker: CAMT returned +102. 6% versus ICHR's +593. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ICHR or CAMT?
By beta (market sensitivity over 5 years), Camtek Ltd.
(CAMT) is the lower-risk stock at 1. 99β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 97% more volatile than CAMT relative to the S&P 500. On balance sheet safety, Ichor Holdings, Ltd. (ICHR) carries a lower debt/equity ratio of 28% versus 38% for Camtek Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — ICHR or CAMT?
By revenue growth (latest reported year), Camtek Ltd.
(CAMT) is pulling ahead at 36. 1% versus 11. 6% for Ichor Holdings, Ltd. (ICHR). On earnings-per-share growth, the picture is similar: Camtek Ltd. grew EPS 50. 3% year-over-year, compared to -140. 6% for Ichor Holdings, Ltd.. Over a 3-year CAGR, CAMT leads at 16. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ICHR or CAMT?
Camtek Ltd.
(CAMT) is the more profitable company, earning 27. 6% net margin versus -5. 6% for Ichor Holdings, Ltd. — meaning it keeps 27. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CAMT leads at 25. 2% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — CAMT leads at 48. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ICHR or CAMT more undervalued right now?
On forward earnings alone, Camtek Ltd.
(CAMT) trades at 56. 7x forward P/E versus 59. 2x for Ichor Holdings, Ltd. — 2. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CAMT: -16. 0% to $165. 60.
08Which pays a better dividend — ICHR or CAMT?
In this comparison, CAMT (0.
6% yield) pays a dividend. ICHR does not pay a meaningful dividend and should not be held primarily for income.
09Is ICHR or CAMT better for a retirement portfolio?
For long-horizon retirement investors, Camtek Ltd.
(CAMT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0. 6% yield, +102. 6% 10Y return). Ichor Holdings, Ltd. (ICHR) carries a higher beta of 3. 93 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CAMT: +102. 6%, ICHR: +593. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ICHR and CAMT?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ICHR is a small-cap quality compounder stock; CAMT is a small-cap high-growth stock. CAMT pays a dividend while ICHR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.